Summary
Gilead Sciences, Inc. (GILD) filed an 8-K on July 23, 2014, to announce its second-quarter financial results for the period ended June 30, 2014. The press release, filed as Exhibit 99.1, provides a detailed look at the company's performance. Gilead presented both GAAP and non-GAAP financial measures, with management highlighting the usefulness of non-GAAP information for investors to better understand operational performance, budgeting, and financial planning, as it is used internally. Investors should note that while the non-GAAP figures offer supplemental insights, they are not prepared under comprehensive accounting rules and should be reviewed alongside the company's official GAAP financial statements. A reconciliation between GAAP and non-GAAP figures is available within the press release itself. This filing primarily serves to disseminate these financial results and does not constitute a broader change in business operations or financial condition beyond the reported quarterly performance.
Key Highlights
- 1Gilead Sciences announced its financial results for the quarter ended June 30, 2014, via an 8-K filing on July 23, 2014.
- 2The company provided financial information using both U.S. Generally Accepted Accounting Principles (GAAP) and non-GAAP measures.
- 3Management believes non-GAAP financial information offers valuable insights for investors, aiding in the understanding of operating results.
- 4Non-GAAP measures are used internally by Gilead for operating, budgeting, and financial planning purposes.
- 5A reconciliation between GAAP and non-GAAP financial information is available in the press release (Exhibit 99.1).
- 6The information in this filing is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, nor incorporated by reference into other filings unless explicitly stated.